این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
The Journal of Tehran University Heart Center، جلد ۸، شماره ۱، صفحات ۱۴-۲۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
چکیده انگلیسی مقاله Background: Despite major advances in percutaneous coronary intervention (PCI), in-stent restenosis (ISR) remains a therapeutic challenge. We sought to compare the mid-term clinical outcomes after treatment with repeat drug-eluting stent (DES) implantation (“DES sandwich” technique) with DES placement in the bare-metal stent (DES-in-BMS) in a "real world" setting. Methods: We retrospectively identified and analyzed clinical and angiographic data on 194 patients previously treated with the DES who underwent repeat PCI for ISR with a DES or a BMS. ISR was defined, by visual assessment, as a luminal stenosis greater than 50% within the stent or within 5 mm of its edges. We recorded the occurrence of major adverse cardiac events (MACE), defined as cardiac death, non-fatal myocardial infarction, and the need for target vessel revascularization (TVR). Results: Of the 194 study participants, 130 were men (67.0%) and the mean ± SD of age was 57.0 ± 10.4 years, ranging from37 to 80 years. In-hospital events (death and Q-wave myocardial infarction) occurred at a similar frequency in both groups. Outcomes at twelve months were also similar between the groups with cumulative clinical MACE at one-year follow-up of 9.6% and 11.3% in the DES-in-BMS and the DES-in-DES groups, respectively (p value = 0.702). Although not significant, there was a trend toward a higher TVR rate in the intra-DES ISR group as compared to the intra-BMS ISR group (0.9% BMS vs. 5.2% DES; p value = 0.16). Conclusion: Our study suggests that the outcome of the patients presenting with ISR did not seem to be different between the two groups of DES-in-DES and DES-in-BMS at one-year follow-up, except for a trend toward more frequent TVR in the DES-in-DES group. Repeat DES implantation for DES restenosis could be feasible and safe with a relatively low incidence of MACE at mid-term follow-up.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Negar Faramarzi
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.


| Mojtaba Salarifar
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.


| SeyedEbrahim Kassaian
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.


| AliMohammad Haji-Zeinali
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.


| Mohammad Alidoosti
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.


| Hamidreza Pourhoseini
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.


| Ebrahim Nematipour
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.


| MohammadReza Mousavi
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.


| Hamidreza Goodarzynejad
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
نشانی اینترنتی http://jthc.tums.ac.ir/index.php/jthc/article/view/276
فایل مقاله اشکال در دسترسی به فایل - ./files/site1/rds_journals/65/article-65-1353677.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات